← Scroll for more →
Cue Biopharma, Inc. (CUE)
Pharmaceutical Preparations
Latest Price
$25.87
TTM P/E
--
Normalized P/E
--
Div Yield
--
Book Value
0.57
P/B Ratio
45.31
Institutional Ownership
31.8% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Bleichroeder LP | 370.7K | $11.0M | 7.09% | -- | 2026-06-30 |
| Driehaus Capital Management LLC | 292.1K | $9.0M | 5.59% | -- | 2026-06-30 |
| Vanguard Capital Management LLC | 161.7K | $5.0M | 3.09% | -- | 2026-06-30 |
| Ikarian Capital, LLC | 104.4K | $3.0M | 2.00% | -- | 2026-06-30 |
| Tetragon Partners GP Ltd | 93.8K | $2.0M | 1.79% | -- | 2026-06-30 |
| Stempoint Capital LP | 67.0K | $2.0M | 1.28% | -- | 2026-06-30 |
| BlackRock, Inc. | 57.8K | $1.0M | 1.11% | -- | 2026-06-30 |
| ADAR1 Capital Management, LLC | 55.2K | $1.0M | 1.06% | -- | 2026-06-30 |
| Lion Point Capital, LP | 52.9K | $1.0M | 1.01% | -- | 2026-06-30 |
| Squadron Capital Management LLC | 50.0K | $1.0M | 0.96% | -- | 2026-06-30 |